|
NADK expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.769900E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.041180E-01 |
| Normal-vs-Stage2 |
6.595200E-01 |
| Normal-vs-Stage3 |
1.676370E-01 |
| Normal-vs-Stage4 |
1.787190E-01 |
| Stage1-vs-Stage2 |
4.997600E-01 |
| Stage1-vs-Stage3 |
9.982800E-01 |
| Stage1-vs-Stage4 |
8.516200E-01 |
| Stage2-vs-Stage3 |
5.395000E-01 |
| Stage2-vs-Stage4 |
4.983800E-01 |
| Stage3-vs-Stage4 |
8.604200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.837560E-01 |
| Normal-vs-AfricanAmerican |
9.317400E-01 |
| Normal-vs-Asian |
1.505360E-01 |
| Caucasian-vs-AfricanAmerican |
4.191200E-01 |
| Caucasian-vs-Asian |
5.163000E-01 |
| AfricanAmerican-vs-Asian |
2.462600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.685600E-01 |
| Normal-vs-Female |
8.703700E-02 |
| Male-vs-Female |
6.845200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.383770E-01 |
| Normal-vs-Age(41-60Yrs) |
1.166410E-01 |
| Normal-vs-Age(61-80Yrs) |
2.586400E-01 |
| Normal-vs-Age(81-100Yrs) |
5.694600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.856000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.783800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.976400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.530800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.871400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.777800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.149000E-01 |
| Classical-VS-Follicular |
1.006180E-01 |
| Classical-VS-Other |
4.779000E-01 |
| Classical-VS-Normal |
3.767200E-01 |
| Tall-VS-Follicular |
6.514600E-01 |
| Tall-VS-Other |
7.403400E-01 |
| Tall-VS-Normal |
2.431000E-01 |
| Follicular-VS-Other |
9.524200E-01 |
| Follicular-VS-Normal |
4.384100E-02 |
| Other-VS-Normal |
2.434000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.561200E-01 |
| Normal-vs-N1 |
2.758300E-03 |
| N0-vs-N1 |
1.676490E-02 |
|
|
